Ranbaxy Loses Bid To Make Generic Flomax

Law360, New York (February 23, 2007, 12:00 AM EST) -- A U.S. federal judge has squashed an attempt by Indian generic drug maker Ranbaxy Laboratories Ltd. to make its own version of Flomax, the enlarged-prostate treatment developed by Japanese pharmaceutical firm Astellas Pharma Inc.

The decision, issued Feb. 21 by Judge Mary L. Cooper in New Jersey District Court, was also a victory for Boehringer Ingelheim Pharmaceuticals Inc., the Ridgefield, Conn.-based company that markets Flomax in the United States.

Ranbaxy filed a notice with the court on Thursday that it was appealing the decision to the...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.